Enhanced Cardiac S100A1 Expression Improves Recovery from Global Ischemia-Reperfusion Injury.

Jungi, Silvan; Fu, X; Segiser, Adrian; Busch, M; Most, P; Fiedler, Georg Martin; Carrel, Thierry; Tevaearai Stahel, H; Henning Longnus, Sarah; Most, Henriette (2018). Enhanced Cardiac S100A1 Expression Improves Recovery from Global Ischemia-Reperfusion Injury. Journal of cardiovascular translational research JCTR, 11(3), pp. 236-245. Springer 10.1007/s12265-018-9788-y

[img] Text
s12265-018-9788-y.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (1MB) | Request a copy

Gene-targeted therapy with the inotropic Ca2 + -sensor protein S100A1 rescues contractile function in post-ischemic heart failure and is being developed towards clinical trials. Its proven beneficial effect on cardiac metabolism and mitochondrial function suggests a cardioprotective effect of S100A1 in myocardial ischemia-reperfusion injury (IRI). Fivefold cardiomyocyte-specific S100A1 overexpressing, isolated rat hearts perfused in working mode were subjected to 28 min ischemia (37 °C) followed by 60 min reperfusion. S100A1 overexpressing hearts showed superior hemodynamic recover: Left ventricular pressure recovered to 57 ± 7.3% of baseline compared to 51 ± 4.6% in control (p = 0.025), this effect mirrored in LV work and dP/dt(max). Troponin T and lactate dehydrogenase was decreased in the S100A1 group, as well as FoxO pro-apoptotic transcription factor, indicating less tissue necrosis, whereas phosphocreatine content was higher after reperfusion. This is the first report of a cardioprotective effect of S100A1 overexpression in a global IRI model.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiovascular Surgery
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Herz- und Gefässchirurgie
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Herz- und Gefässchirurgie

UniBE Contributor:

Jungi, Silvan; Segiser, Adrian; Fiedler, Georg Martin; Carrel, Thierry and Henning Longnus, Sarah

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1937-5387

Publisher:

Springer

Language:

English

Submitter:

Daniela Huber

Date Deposited:

04 Jun 2018 15:30

Last Modified:

04 Jun 2018 15:30

Publisher DOI:

10.1007/s12265-018-9788-y

PubMed ID:

29392537

Uncontrolled Keywords:

Cardioprotection Inotropic therapy Ischemia-reperfusion injury S100A1

BORIS DOI:

10.7892/boris.116916

URI:

https://boris.unibe.ch/id/eprint/116916

Actions (login required)

Edit item Edit item
Provide Feedback